POLARISqb will revolutionize drug design by joining Quantum Computing with AI and Precision Medicine. Our platform will produce up to 100 drug blueprints per year. We will compress the lead time for preclinical drug candidates from 5 years to 4 months, enabling real time adaptability to the precision medicine market. POLARISqb will own an IP portfolio of drug assets to license, sell, or develop internally.
POLARISqb will use Quantum Computing to search unstructured, exponentially large datasets to explore novel chemical space, and create new drugs. Artificial Intelligence tools, especially Machine Learning (AI/ML) algorithms utilizing Big Data, are used to remove drug toxicity effects. Platform automation and scale will bring the power of these tools to bear on our mission.
The cost of personal genome sequencing is decreasing and is projected to be less than $1,000 per person by 2020. This allows for a better understanding of disease biology, and discovery of more specific disease pathways leading to smaller and more precise patient groups. This Precision Medicine toolbox identifies the proteins that POLARISqb will use to create the drug blueprints in our portfolio.
Most drugs are small molecules that have been optimized to manipulate the right biology (alter disease state) without harming the rest of the body. Developing drugs is currently a lengthy (10 years) and expensive (> $1B) process. At POLARISqb, automation and scale will significantly shorten and lower the cost of the process. Reducing cost and time to market of our drug candidates enhances the value of our IP portfolio.
We’re transforming health for people everywhere, by the fast creation of drug blueprints for all human proteins, disease pathways, genetic mutations and pathogens.
We unite the powers of Quantum Computing, AI and Precision Medicine to search chemical space and create novel molecular drugs for specific proteins and diseases.
POLARISqb is using the most advanced technology to create drugs to fight diseases that have plagued humans for millennia. We are uniting the three sciences: Physics (Quantum Computing), Biology (Genetics) and Chemistry (Molecular drugs), to create our designs, build a unique IP portfolio and change the way new drugs are developed. I am proud to be part of the POLARISqb team and our vision.
I am excited by the bright future unfolding as we leverage the Quantum Computing revolution to create novel drugs to service the needs of the world. We are able to harness the Big Data transformation within modern medicine giving rise to Precision Medicine to selectively target disease processes which have previously been 'undruggable'.
March 16, 2020
March 16, 2020
March 16, 2020
March 18, 2020
POLARISqb is looking for the best and brightest minds to join our team. We foster a culture of diversity, positivity and innovation as we seek to change the way new drugs are developed. If you're a quantum computing engineer, computational or medicinal chemist, full stack developer, business development or sales executive, reach out at email@example.com.